Turnstone Biologics

Startup grabbed headlines in late 2016 when it raised US$41 million in a series-B venture capital financing round
Report highlights firms that are likely to scale up and reach “world-class status,” eventually going public or reaching a “unicorn” valuation of $1B.
Local firm was recently named one of the world’s top 15 biotech startups.
An Ottawa biotech startup has received a US$41-million injection of venture capital to further develop its groundbreaking treatments that use the body’s own immune system to battle cancer.